Target
Apoptosis regulator Bcl-2
Ligand
BDBM356662
Substrate
n/a
Meas. Tech.
Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET) Assay
Ki
<0.010±n/a nM
Citation
 Bruncko, MDing, HDoherty, GAElmore, SWHasvold, LAHexamer, LKunzer, ARSong, XSouers, AJSullivan, GMTao, ZWang, GTWang, LWang, XWendt, MDMantei, RHansen, TM APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES US Patent  US20240043404 Publication Date 2/8/2024 
Target
Name:
Apoptosis regulator Bcl-2
Synonyms:
Apoptosis regulator Bcl-2 Protein | B-cell lymphoma 2 protein (Bcl-2) | BCL-2 | BCL2 | BCL2_HUMAN | Bcl-2 Protein
Type:
Homodimer or heterodimer
Mol. Mass.:
26269.11
Organism:
Homo sapiens (Human)
Description:
P10415
Residue:
239
Sequence:
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK
  
Inhibitor
Name:
BDBM356662
Synonyms:
US10213433, Compound 44 | US11369599, Compound 44 | US20240043404, Example 44 | trans-4-(4-{[4-(4-chlorophenyl)-6,6-dimethyl-5,6-dihydro-2H-pyran-3-yl]methyl}piperazin-1-yl)-N-({4-[(4-morpholin-4-ylcyclohexyl)amino]-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
Type:
Small organic molecule
Emp. Form.:
C49H55ClF3N7O8S2
Mol. Mass.:
1026.581
SMILES:
CC1(C)CC(=C(CN2CCN(CC2)c2ccc(C(=O)NS(=O)(=O)c3ccc(N[C@H]4CC[C@@H](CC4)N4CCOCC4)c(c3)S(=O)(=O)C(F)(F)F)c(Oc3cnc4[nH]ccc4c3)c2)CO1)c1ccc(Cl)cc1 |wU:28.28,wD:31.35,t:4,(3.59,13.27,;2.82,11.93,;4.36,11.93,;1.48,12.71,;.15,11.93,;.15,10.39,;-1.18,9.63,;-1.18,8.08,;-2.52,7.32,;-2.52,5.78,;-1.18,5,;.15,5.78,;.15,7.32,;-1.18,3.46,;-2.52,2.7,;-2.52,1.16,;-1.18,.38,;-1.18,-1.16,;-2.52,-1.93,;.15,-1.93,;.15,-3.46,;-1.39,-3.46,;1.69,-3.46,;.15,-5,;-1.18,-5.78,;-1.18,-7.32,;.15,-8.08,;.15,-9.63,;-1.18,-10.39,;-1.18,-11.93,;-2.52,-12.71,;-3.85,-11.93,;-3.85,-10.39,;-2.52,-9.63,;-5.19,-12.71,;-5.19,-14.24,;-6.52,-15.01,;-7.85,-14.24,;-7.85,-12.71,;-6.52,-11.93,;1.48,-7.32,;1.48,-5.78,;2.82,-8.08,;2.05,-9.42,;3.59,-6.75,;4.15,-8.86,;5.48,-8.08,;4.15,-10.39,;5.48,-9.63,;.15,1.16,;1.48,.38,;2.82,1.16,;2.82,2.7,;4.15,3.46,;5.48,2.7,;6.95,3.17,;7.85,1.93,;6.95,.68,;5.48,1.16,;4.15,.38,;.15,2.7,;1.48,9.63,;2.82,10.39,;-1.18,12.71,;-2.52,11.93,;-3.85,12.71,;-3.85,14.24,;-5.19,15.01,;-2.52,15.01,;-1.18,14.24,)|
Structure:
Search PDB for entries with ligand similarity: